Specialties and Expertise
- Ankylosing Spondylitis
- Psoriatic Arthritis
- Takayasu's Arteritis
- Giant Cell Arteritis With Polymyalgia Rheumatica
- Granulomatosis With Polyangiitis (Wegener's)
- Mixed Connective Tissue Disease
- Sjogren's Syndrome
- Antiphospholipid Syndrome
- Systemic Lupus Erythematosus
- Rheumatoid Arthritis
- Autoimmune Disorder
- Churg Strauss Vasculitis
- Crohn's Disease Associated With Arthritis
- Ulcerative Colitis Associated With Arthritis
- Reactive Arthritis
- Reiter's Syndrome
- Generalized Osteoarthritis
- Osteoarthritis of Spine
Dr. Paget was the Physician-in-Chief and Chairman of the Division of Rheumatology at Hospital For Special Surgery and the Joseph P. Routh Professor of Medicine and Rheumatic Disease at the Weill Medical College of Cornell University and the New York Presbyterian Hospital for fifteen years and is now the Physician-in-Chief Emeritus. As Chair, he developed and ran a world-class rheumatology division of 46 physicians, scientists and clinician-scholar educators who were focused on clinical, perioperative and consultative care throughout HSS and the York Avenue institutions, basic, translational and clinical and drug trials research and musculoskeletal education to medical students, residents and fellows.
During his time at the NIH and upon arriving at HSS in 1975, his basic immunologic research focused on defining the immunopathogenesis of rheumatoid arthritis. As an Associate Director of an NIH-funded Cornell Multipurpose Arthritis Center, he focused his clinical and translational research on the areas of steroid-induced osteoporosis, systemic vasculitides, rheumatoid arthritis, joint replacements and hip fractures. Most recently, Dr. Paget was a director of the Mary Kirkland Center for Lupus Research at HSS and on the Board of Directors of the Lupus Clinical Trials Consortium and his investigation was directed at attaining a broader understanding of premature atherosclerosis in autoimmune disorders.
He was a Member of the Board of Directors of the American Board of Internal Medicine and the Co-Chair of the rheumatology subspecialty Board. He has been a member of the Board of Directors of the Research and Education Foundation of the American College of Rheumatology and the Chair of its Development Advisory Council. He was recently honored by receiving the American College of Rheumatology’s Master designation and Distinguished Clinical Scholar award. He was a longstanding member of the Board of Trustees of the New York Arthritis Foundation.
Dr. Paget received his MD degree from Downstate Medical Center, did his residency in Internal Medicine at Johns Hopkins and was a Clinical Associate at the National Institute of Arthritis, Musculoskeletal and Skin diseases.
Dr. Paget has both national and international recognition as a Master Clinician in a broad range of inflammatory and autoimmune disorders. As a Clinician-Scholar Educator he has had a significant impact upon rheumatology education and is currently the Director of the HSS Rheumatology Academy of Medical Educators.
Honors and Awards
Honors and Awards
Master of the American College of Rheumatology
Distinguished Clinical Scholar, American College of Rheumatology
HSS Lifetime Achievement Award
Wholeness of Life Award
Clinical and Academic Positions
- Attending Physician - Hospital for Special Surgery
- Attending Physician - NewYork-Presbyterian Hospital
- Professor of Medicine - Weill Cornell Medical College, Cornell University
Education and Training
- M.D., State University of New York Health Science Center at Brooklyn, 1971
Insurance Plans Accepted
For relevant information regarding accepted insurances, please contact this provider directly.
Locations and Appointments
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.
No External Relationships Reported